Ibrutinib-Related Uveitis: A Case Series from Two Tertiary Centres in the United Kingdom
Our case series provides evidence suggestive of a connection between ibrutinib and development of uveitis. Ibrutinib related uveitis appears to be more common than previously recognised. Ibrutinib cessation, if appropriate, appears to be the definitive management. Patients with ibrutinib-related uveitis benefit from multidisciplinary management involving communication between ophthalmologist and haemato-oncologist.
Authors
- Jennifer Kwan (ORCID: https://orcid.org/0000-0002-8321-5693)
- Nicholas A. V. Beare (ORCID: https://orcid.org/0000-0001-8086-990X)
- Chung Shen Chean (ORCID: https://orcid.org/0000-0002-1625-4078)
- Anita J. M. Kalakonda
- Stella Williams
- Periyasamy Kumar
- Hagar Ibrahim
Institutions
- University of Liverpool (GB)
- University Hospitals of Leicester NHS Trust (GB)
- Clatterbridge Cancer Centre NHS Foundation Trust (GB)
Publication Details
- Journal
- Ocular Immunology and Inflammation
- Published
- 2024-09-06
- DOI
- https://doi.org/10.1080/09273948.2024.2396007
- Citations
- 3
- Primary Topic
- Chronic Lymphocytic Leukemia Research
- Type
- article
- Field-Weighted Citation Impact
- 1.31